NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock was up 1.4% higher at $40.62 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...

Loreen's UK and Ireland 2025 tour setlist in full ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

Converse projects the Thunder's SGA logo over the city of Boston after their win against the Celtics, which clinches a playoff berth.

TransAct Technologies Incorporated reported its fourth-quarter 2024 earnings, revealing a net sales decline of 23% year-over-year to $10.2 million. Despite the revenue shortfall against forecasts, the ...